NCT04648189 2023-10-19
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
The Netherlands Cancer Institute
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT04280640 2021-10-18
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT03161834 2021-05-21
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT02742259 2019-03-26
VPCA-B+PIV
Celsee Diagnostics
Withdrawn
NCT02621190 2016-08-17
CARVE
Erasmus Medical Center
Phase 2 Withdrawn
NCT02065323 2015-01-19
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Comprehensive Cancer Centers of Nevada
Phase 2 Withdrawn